Luminous Ventures is pleased to announce that BioBeats, our portfolio company and one of the first digital health companies targeting mental health and one of the first applying deep learning to healthcare data, has become part of Medopad (rebranded as Huma).

BioBeats is a leader in using AI to both quantify stress as well as determine interventions. Medopad is one of the largest and fastest growing digital health companies in the UK and the ideal place for the BioBeats technology to continue to develop and expand its reach and impact significantly.

Luminous team have been with BioBeats’s journey since 2016 and have been really pleased to see the company’s amazing progress. Sincere congratulations to all involved.

For more details please refer to the press article on TechCrunch and the official release from Huma.